Mechanism of Action of Gliclazide Extended-Release Tablets

Hello, Gliclazide Modified-Release Tablets are a commonly used sulfonylurea antidiabetic agent in clinical practice. Its primary therapeutic effect is to lower blood glucose levels and it is typically indicated for the treatment of type 2 diabetes mellitus—particularly in adult patients with non-insulin-dependent type 2 diabetes whose blood glucose remains inadequately controlled despite lifestyle interventions such as weight reduction or exercise. This medication provides relatively stable glycemic control and is therefore best administered at breakfast time. It is contraindicated in patients with type 1 diabetes. During treatment, patients should regularly visit their healthcare provider for blood glucose monitoring. We hope this information is helpful to you. Wishing you good health and happiness!